Minibeam brain sparing persists without mature T cells in rat experiments

At six months after 30-Gy minibeam irradiation, rats lacking mature T cells showed preserved brain structure despite greater early tissue reactions.

KEY POINTS

  • This preclinical study from Institut Curie and collaborating French and Spanish laboratories evaluated whether mature T cells are required for long-term normal brain preservation after minibeam radiation therapy (MBRT). The investigators used 78 six-week-old male rats, including 48 immunocompetent Fischer 344 rats and 30 athymic nude rats lacking mature T cells; two animals died from anesthesia-related complications before analysis. Brain injury was evaluated using behavioral testing, 7-T MRI, immunohistochemistry, and assessments of vascular, glial, neuronal, and immune responses through six months.
  • MBRT delivered a highly heterogeneous spatial dose distribution rather than uniform irradiation. A 220-kVp x-ray source generated minibeams measuring 700 ± 40 μm wide, with 1,400 ± 100 μm center-to-center spacing. The mean prescribed dose was 30 Gy, corresponding to peak doses of 83 ± 7 Gy and valley doses of 4.5 ± 0.3 Gy. Conventional radiotherapy (CRT) delivered a homogeneous 30-Gy broad beam and was included for selected acute comparisons, but no concurrent six-month conventional-RT control arm was evaluated.
  • Mature T-cell deficiency increased some early radiation effects without abolishing later tissue preservation. Beam-path alopecia appeared approximately 9–10 days after MBRT in nude rats, compared with 20–21 days in immunocompetent animals. At seven days, nude rats also demonstrated transient reductions in cortical CD31-positive vascular staining and vessel density, whereas the corresponding changes were less pronounced in immunocompetent animals. By six months, no persistent vascular differences attributable to MBRT were detected in either strain.
  • Long-term brain structure remained preserved regardless of mature T-cell status. At six months, contrast-enhanced MRI showed no detectable brain lesions, abnormal enhancement, or ventricular enlargement in either irradiated strain. NeuN immunohistochemistry demonstrated no significant loss of neuronal density, while sustained microglial or astrocytic activation was not detected. These findings support a relatively preserved structural phenotype after MBRT, although conventional irradiation at the same mean dose was not directly assessed at this late time point.
  • MBRT produced a transient immune response that differed from conventional irradiation. In immunocompetent animals, CD3-positive T-cell infiltration increased significantly 12 hours after MBRT (p=0.001) but resolved by day seven. Conventional broad-beam irradiation induced a substantially larger early CD3-positive infiltrate (p<0.0001) with more persistent inflammation. MBRT did not significantly increase GFAP-positive astrocytic area, whereas conventional irradiation produced early astrocytic activation. These findings suggest that adaptive immune-cell recruitment is not the only determinant of the tissue response.
  • Subtle behavioral differences remained despite preserved structural imaging and histology. At six months, MBRT reduced exploratory rearing activity (p=0.010) and novel-object discrimination performance (p=0.032), while time spent in the center zone increased at three months (p=0.045). However, there was no significant interaction between animal strain and irradiation for the behavioral outcomes, suggesting that the observed changes did not depend strongly on mature T-cell presence. Thus, the absence of visible structural brain injury should not be equated with complete preservation of neurological function.
  • The model was insufficiently powered to exclude modest immune contributions. Post hoc analysis showed adequate power only for large effects, approximately 22–64% of control means across principal endpoints. Athymic rats retained B cells, natural killer cells, and innate immunity, while only male animals were studied. In addition, circulating inflammatory mediators were not measured, and MRI or neuronal density assessment cannot exclude subtle synaptic or microstructural injury. The findings therefore establish that mature T cells are not required for the observed six-month sparing phenotype under these experimental conditions, rather than proving that adaptive immunity has no role in MBRT.

CLINICAL TAKEAWAY

Minibeam irradiation preserved major structural features of normal brain tissue in rats regardless of mature T-cell status, suggesting that vascular, innate immune, or stromal mechanisms may contribute to its normal-tissue-sparing properties. However, early tissue reactions differed between immunocompetent and T-cell-deficient animals, and modest behavioral changes persisted despite normal structural imaging. These findings are mechanistic and do not establish clinical neuroprotection or justify changes in radiotherapy delivery.

SOURCE

International Journal of Radiation Oncology, Biology, Physics

Browse more research Suggest a correction